252 related articles for article (PubMed ID: 28187877)
1. Timing of initiation of adjuvant chemotherapy for gastric cancer: A case-matched comparison study of laparoscopic vs. open surgery.
Kaito A; Kinoshita T; Shitara K; Shibasaki H; Nishida T
Eur J Surg Oncol; 2017 Apr; 43(4):801-807. PubMed ID: 28187877
[TBL] [Abstract][Full Text] [Related]
2. Totally Laparoscopic versus Open Gastrectomy for Gastric Cancer: a Matched Pair Analysis.
Ludwig K; Schneider-Koriath S; Scharlau U; Steffen H; Möller D; Bernhardt J
Zentralbl Chir; 2018 Apr; 143(2):145-154. PubMed ID: 29719906
[TBL] [Abstract][Full Text] [Related]
3. Long- and short-term outcomes of laparoscopic gastrectomy versus open gastrectomy in patients with clinically and pathological locally advanced gastric cancer: a propensity-score matching analysis.
Inokuchi M; Nakagawa M; Tanioka T; Okuno K; Gokita K; Kojima K
Surg Endosc; 2018 Feb; 32(2):735-742. PubMed ID: 28726137
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Adjuvant S-1 Versus XELOX Chemotherapy for Patients with Gastric Cancer After D2 Lymph Node Dissection: A Retrospective, Multi-Center Observational Study.
Kim IH; Park SS; Lee CM; Kim MC; Kwon IK; Min JS; Kim HI; Lee HH; Lee SI; Chae H
Ann Surg Oncol; 2018 May; 25(5):1176-1183. PubMed ID: 29450755
[TBL] [Abstract][Full Text] [Related]
5. Clinical Impact of Laparoscopic Surgery on the Long-term Survival of Advanced Gastric Cancer Patients With Regard to Facilitating Doublet Adjuvant Chemotherapy.
Morino K; Yamamoto M; Yamanaka R; Iwasaki Y; Nakanishi N; Goto T; Tanaka H; Matsusue R; Machimoto T
Anticancer Res; 2023 May; 43(5):2203-2209. PubMed ID: 37097653
[TBL] [Abstract][Full Text] [Related]
6. Lymph-node ratio is an important clinical determinant for selecting the appropriate adjuvant chemotherapy regimen for curative D2-resected gastric cancer.
Hwang JE; Kim H; Shim HJ; Bae WK; Hwang EC; Jeong O; Ryu SY; Park YK; Cho SH; Chung IJ
J Cancer Res Clin Oncol; 2019 Aug; 145(8):2157-2166. PubMed ID: 31273512
[TBL] [Abstract][Full Text] [Related]
7. Time to initiation or duration of S-1 adjuvant chemotherapy; which really impacts on survival in stage II and III gastric cancer?
Fujitani K; Kurokawa Y; Takeno A; Endoh S; Ohmori T; Fujita J; Yamasaki M; Takiguchi S; Mori M; Doki Y;
Gastric Cancer; 2018 May; 21(3):446-452. PubMed ID: 28965205
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.
Tsuburaya A; Mizusawa J; Tanaka Y; Fukushima N; Nashimoto A; Sasako M;
Br J Surg; 2014 May; 101(6):653-60. PubMed ID: 24668391
[TBL] [Abstract][Full Text] [Related]
9. A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02.
Choi YH; Oh SC; Kim JS; Nam SH; Kim BS; Cho SH; Chung IJ; Song EK; Yim CY; Baek JH; Jeung HC; Hong YS; Yang SH; Kang HJ
Cancer Chemother Pharmacol; 2012 Nov; 70(5):665-72. PubMed ID: 22926638
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic Versus Open Gastrectomy for Cancer: A Western Center Cohort Study.
Tsekrekos A; Klevebro F; Hayami M; Kamiya S; Lindblad M; Nilsson M; Lundell L; Rouvelas I
J Surg Res; 2020 Mar; 247():372-379. PubMed ID: 31679797
[TBL] [Abstract][Full Text] [Related]
11. Comparison of capecitabine and oxaliplatin with S-1 as adjuvant chemotherapy in stage III gastric cancer after D2 gastrectomy.
Cho JH; Lim JY; Cho JY
PLoS One; 2017; 12(10):e0186362. PubMed ID: 29040299
[TBL] [Abstract][Full Text] [Related]
12. Application of Laparoscopic Gastrectomy in Obese Patients (BMI≥30 kg/m2) with Gastric Cancer: A Comparison With Open Gastrectomy Regarding Short-term Outcomes.
Chen K; Pan Y; Yu WH; Zheng XY; Zhu LH; Wang XF
Surg Laparosc Endosc Percutan Tech; 2018 Feb; 28(1):e18-e23. PubMed ID: 29176372
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy.
Shitara K; Chin K; Yoshikawa T; Katai H; Terashima M; Ito S; Hirao M; Yoshida K; Oki E; Sasako M; Emi Y; Tsujinaka T
Gastric Cancer; 2017 Jan; 20(1):175-181. PubMed ID: 26626800
[TBL] [Abstract][Full Text] [Related]
14. A prospective randomized study comparing open versus laparoscopy-assisted D2 radical gastrectomy in advanced gastric cancer.
Cai J; Wei D; Gao CF; Zhang CS; Zhang H; Zhao T
Dig Surg; 2011; 28(5-6):331-7. PubMed ID: 21934308
[TBL] [Abstract][Full Text] [Related]
15. A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002.
Ito S; Sano T; Mizusawa J; Takahari D; Katayama H; Katai H; Kawashima Y; Kinoshita T; Terashima M; Nashimoto A; Nakamori M; Onaya H; Sasako M
Gastric Cancer; 2017 Mar; 20(2):322-331. PubMed ID: 27299887
[TBL] [Abstract][Full Text] [Related]
16. Safety of laparoscopic radical gastrectomy in gastric cancer patients with liver cirrhosis.
Kim DJ; Park CH; Kim W; Jin HM; Kim JJ; Lee HH; Lee JH
Surg Endosc; 2017 Oct; 31(10):3898-3904. PubMed ID: 28205032
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study.
Lee SJ; Sohn TS; Lee J; Park SH; Park JO; Lim DH; Park YS; Lim HY; Choi MG; Lee JH; Bae JM; Kim S; Kang WK
Anticancer Res; 2014 Nov; 34(11):6585-91. PubMed ID: 25368262
[TBL] [Abstract][Full Text] [Related]
18. Surgical outcomes in patients with locally advanced gastric cancer treated with S-1 and oxaliplatin as neoadjuvant chemotherapy.
Feng D; Leong M; Li T; Chen L; Li T
World J Surg Oncol; 2015 Jan; 13():11. PubMed ID: 25634099
[TBL] [Abstract][Full Text] [Related]
19. Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial.
Hu Y; Huang C; Sun Y; Su X; Cao H; Hu J; Xue Y; Suo J; Tao K; He X; Wei H; Ying M; Hu W; Du X; Chen P; Liu H; Zheng C; Liu F; Yu J; Li Z; Zhao G; Chen X; Wang K; Li P; Xing J; Li G
J Clin Oncol; 2016 Apr; 34(12):1350-7. PubMed ID: 26903580
[TBL] [Abstract][Full Text] [Related]
20. Surgical and long-term oncologic outcomes of laparoscopic and open gastrectomy for serosa-positive (pT4a) gastric cancer: A propensity score-matched analysis.
Li Z; Liu Y; Hao Y; Bai B; Yu D; Zhao Q
Surg Oncol; 2019 Mar; 28():167-173. PubMed ID: 30851895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
